Sylviane Muller

Q: What Schools Are Affiliated With Sylviane Muller

Sylviane Muller is affiliated with the following schools: University of Rennes 1, University of Trieste, University of Strasbourg, University of Würzburg

Sylviane Muller's AcademicInfluence.com Rankings

Sylviane Muller

Philosophy

#8526

World Rank

#11931

Historical Rank

Logic

#5558

World Rank

#6965

Historical Rank

philosophy Degrees

Sylviane Muller

Biology

#11562

World Rank

#14966

Historical Rank

Immunology

#748

World Rank

#770

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Sylviane Muller's Degrees

PhD Immunology University of Strasbourg
Doctorate Medicine University of Strasbourg

Why Is Sylviane Muller Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Sylviane Muller's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (2012) (2913)
Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. (2007) (1009)
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 (2021) (811)
Autoantigen microarrays for multiplex characterization of autoantibody responses (2002) (671)
Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. (2006) (647)
Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. (2003) (480)
The cytopathic effect of HIV is associated with apoptosis. (1991) (381)
High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. (1997) (380)
Asymmetry in Histone H3 variants and lysine methylation between paternal and maternal chromatin of the early mouse zygote (2005) (340)
CXCR3, Inflammation, and Autoimmune Diseases (2009) (323)
Endotoxin‐free heat‐shock protein 70 fails to induce APC activation (2002) (274)
Synthetic peptides as antigens: pitfalls of conjugation methods. (1985) (274)
Lysosomes as a therapeutic target (2019) (249)
The SARS-CoV-2 as an instrumental trigger of autoimmunity (2021) (243)
Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. (2003) (241)
Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties. (2005) (236)
Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. (1993) (217)
HSPA8/HSC70 chaperone protein (2013) (207)
Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers (2014) (204)
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response. (2015) (188)
An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy. (2017) (178)
Nucleosomes and histones are present in glomerular deposits in human lupus nephritis. (1995) (160)
Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics. (1994) (152)
Macroautophagy is deregulated in murine and human lupus T lymphocytes (2012) (147)
Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial (2012) (145)
Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. (2005) (132)
Anti‐SSA/Ro52 autoantibodies blocking the cardiac 5‐HT4 serotoninergic receptor could explain neonatal lupus congenital heart block (2000) (124)
Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. (2007) (123)
T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MRL/lpr mice (2003) (118)
Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences. (2002) (112)
Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial. (2008) (111)
HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus (2010) (108)
Synthetic Polypeptides As Antigens (1988) (98)
Epigenetic Histone Code and Autoimmunity (2010) (90)
Comparison of different methods for localizing antigenic regions in histone H2A. (1986) (89)
Application and limitations of the multiple antigen peptide (MAP) system in the production and evaluation of anti-peptide and anti-protein antibodies. (1992) (89)
A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins. (2011) (88)
Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies. (2009) (85)
D-peptides as immunogens and diagnostic reagents. (1998) (84)
Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19 (2020) (83)
Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus (2010) (79)
Autoantibodies typical of non‐organ‐specific autoimmune diseases in HIV‐seropositive patients (1992) (78)
A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies. (1997) (78)
Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: the MRL-lpr mouse strain as a model. (2014) (75)
Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide (2015) (74)
The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an efficient B cell epitope vaccine candidate against virus infection. (2004) (72)
Antigenicity and immunogenicity of modified synthetic peptides containing D-amino acid residues. Antibodies to a D-enantiomer do recognize the parent L-hexapeptide and reciprocally. (1993) (72)
T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice. (2003) (71)
The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity (2002) (71)
Presence of antibodies to ubiquitin during the autoimmune response associated with systemic lupus erythematosus. (1988) (68)
Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7. (2001) (67)
Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunity (2014) (65)
Antigenic properties and protective capacity of a cyclic peptide corresponding to site A of influenza virus haemagglutinin. (1990) (65)
Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. (2010) (64)
Citrullinated Autoantigens: From Diagnostic Markers to Pathogenetic Mechanisms (2015) (63)
The Spliceosomal Phosphopeptide P140 Controls the Lupus Disease by Interacting with the HSC70 Protein and via a Mechanism Mediated by γδ T Cells (2009) (62)
Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice. (2001) (62)
HIV-1 Tat protein directly induces mitochondrial membrane permeabilization and inactivates cytochrome c oxidase (2012) (59)
Recognition of synthetic peptides of Sm‐D autoantigen by lupus sera (1990) (58)
Hepatoma tissue culture (HTC) cells as a model for investigating the effects of low concentrations of herbicide on cell structure and function. (2008) (57)
Transcutaneous immunization with tetanus toxoid and mutants of Escherichia coli heat-labile enterotoxin as adjuvants elicits strong protective antibody responses. (2003) (57)
Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine (2020) (57)
Immunization onto bare skin with heat‐labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge (2001) (56)
Selective Modulation of CD4+ T Cells from Lupus Patients by a Promiscuous, Protective Peptide Analog1 (2005) (56)
B and T cell immune response to small nuclear ribonucleoprotein particles in lupus mice: autoreactive CD4+ T cells recognize a T cell epitope located within the RNP80 motif of the 70K protein (2000) (56)
Early Differentiated CD138highMHCII+IgG+ Plasma Cells Express CXCR3 and Localize into Inflamed Kidneys of Lupus Mice (2013) (55)
Pathogenic anti-nucleosome antibodies (2008) (55)
HSPA8/HSC70 in Immune Disorders: A Molecular Rheostat that Adjusts Chaperone-Mediated Autophagy Substrates (2019) (54)
A lipoyl synthetic octadecapeptide of dihydrolipoamide acetyltransferase specifically recognized by anti-M2 autoantibodies in primary biliary cirrhosis. (1992) (54)
Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells. (2008) (53)
52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block (2005) (53)
IgG antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize different epitopes in 60‐kD SSA/Ro protein (1992) (53)
Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG‐containing oligodeoxynucleotide and effective priming of influenza virus‐specific CD4+ T cells (2002) (52)
Recognition of Human Proinsulin Leader Sequence by Class I–Restricted T-Cells in HLA-A*0201 Transgenic Mice and in Human Type 1 Diabetes (2009) (52)
Glomerular immune deposits in murine lupus models may contain histones (1992) (51)
Mapping of epitopes on Ul snRNP polypeptide A with synthetic peptides and autoimmune sera (1991) (51)
Reactivity of autoantibodies in systemic lupus erythematosus with synthetic core histone peptides. (1989) (51)
Pharmacological regulators of autophagy and their link with modulators of lupus disease (2014) (51)
Immunochemical localization of the C‐terminal hexapeptide of histone H3 at the surface of chromatin subunits. (1982) (50)
Importance of spliceosomal RNP1 motif for intermolecular T-B cell spreading and tolerance restoration in lupus (2007) (50)
Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lipid A. (1993) (50)
Manipulating Autophagic Processes in Autoimmune Diseases: A Special Focus on Modulating Chaperone-Mediated Autophagy, an Emerging Therapeutic Target (2015) (49)
Peptide-based approaches to treat lupus and other autoimmune diseases. (2012) (49)
Synthetic peptides as antigens (1999) (49)
Immunity under the skin: potential application for topical delivery of vaccines. (2003) (48)
Specificity of antibodies raised against triacetylated histone H4. (1987) (47)
In vivo T helper cell response to retro-inverso peptidomimetics. (1997) (47)
The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera. (2000) (47)
Use of histone antibodies for studying chromatin topography and the phosphorylation of chromatin subunits. (1984) (47)
Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2. (1996) (47)
T Cell Response to Preproinsulin I and II in the Nonobese Diabetic Mouse1 (2002) (46)
Interfacing Functionalized Carbon Nanohorns with Primary Phagocytic Cells (2008) (45)
Autophagy in neuroinflammatory diseases. (2017) (44)
Key Sequences Involved in the Spreading of the Systemic Autoimmune Response to Spliceosomal Proteins (2001) (44)
The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro (2008) (43)
A branched, synthetic octapeptide of ubiquitinated histone H2A as target of autoantibodies (1989) (42)
Mapping of linear histone regions exposed at the surface of the nucleosome in solution. (1997) (42)
Apoptosis-linked changes in the phosphorylation status and subcellular localization of the spliceosomal autoantigen U1-70K (2008) (41)
TREM-1 Inhibition Restores Impaired Autophagy Activity and Reduces Colitis in Mice (2018) (41)
Immunochemical detection of changes in chromatin subunits induced by histone H4 acetylation. (1982) (40)
Aberrant Expression of the Autoantigen Heterogeneous Nuclear Ribonucleoprotein-A2 (RA33) and Spontaneous Formation of Rheumatoid Arthritis-Associated Anti-RA33 Autoantibodies in TNF-α Transgenic Mice1 (2005) (40)
Antigenic structure of histone H2B. (1985) (39)
The mechanism of HIV-1 Tat-directed nucleic acid annealing supports its role in reverse transcription. (2010) (39)
Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option. (2018) (39)
Antibodies from patients with rheumatoid arthritis and juvenile chronic arthritis analyzed with core histone synthetic peptides. (1990) (39)
The LTR72 Mutant of Heat-Labile Enterotoxin of Escherichia coli Enhances the Ability of Peptide Antigens To Elicit CD4+ T Cells and Secrete Gamma Interferon after Coapplication onto Bare Skin (2002) (38)
Parameters affecting the immunogenicity of a liposome‐associated synthetic hexapeptide antigen (1991) (38)
The bare skin and the nose as non-invasive routes for administering peptide vaccines. (2001) (37)
Effect of Skin Barrier Disruption on Immune Responses to Topically Applied Cross-Reacting Material, CRM197, of Diphtheria Toxin (2005) (37)
Automatic Sequence Design of Major Histocompatibility Complex Class I Binding Peptides Impairing CD8+ T Cell Recognition* 210 (2003) (37)
Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis (2016) (37)
What Has Come out from Phytomedicines and Herbal Edibles for the Treatment of Cancer? (2018) (37)
CD4 T cell autophagy is integral to memory maintenance (2018) (36)
Improvement of collagen-induced arthritis by active immunization against murine IL-1beta peptides designed by molecular modelling. (2005) (36)
Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects (2009) (36)
Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death. (1996) (36)
From Systemic Inflammation to Neuroinflammation: The Case of Neurolupus (2018) (35)
B and T Cell Responses to the Spliceosomal Heterogeneous Nuclear Ribonucleoproteins A2 and B1 in Normal and Lupus Mice1 (2000) (35)
ATG5 is required for B cell polarization and presentation of particulate antigens (2018) (35)
Single Insulin-Specific CD8+ T Cells Show Characteristic Gene Expression Profiles in Human Type 1 Diabetes (2011) (35)
Longitudinal analysis of antibodies to histones, Sm-D peptides and ubiquitin in the serum of patients with systemic lupus erythematosus, rheumatoid arthritis and tuberculosis. (1990) (34)
Rescue of autophagy and lysosome defects in salivary glands of MRL/lpr mice by a therapeutic phosphopeptide. (2018) (34)
Selective induction of protection against influenza virus infection in mice by a lipid-peptide conjugate delivered in liposomes. (1994) (34)
Identification of a Minimal T Cell Epitope Recognized by Antinucleosome Th Cells in the C-Terminal Region of Histone H41 (2000) (33)
A partially modified retro-inverso pseudopeptide modulates the cytokine profile of CTL specific for an influenza virus epitope. (1998) (33)
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 (2016) (33)
The cell nuclei of skeletal muscle cells are transcriptionally active in hibernating edible dormice (2009) (32)
Solid-phase synthesis of "mixed" peptidomimetics using Fmoc-protected aza-beta3-amino acids and alpha-amino acids. (2005) (32)
Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection. (2004) (32)
New Zealand white rabbits immunized with RNA‐complexed total histones develop an autoimmune‐like response (1991) (32)
Decision-making at the surface of the intact or barrier disrupted skin: potential applications for vaccination or therapy (2005) (32)
Intramolecular T cell spreading in unprimed MRL/lpr mice: importance of the U1-70k protein sequence 131-151. (2004) (32)
Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652 (2016) (31)
Identification of New Pathogenic Players in Lupus: Autoantibody-Secreting Cells Are Present in Nephritic Kidneys of (NZBxNZW)F1 Mice (2010) (31)
Assessing Autophagy in Mouse Models and Patients with Systemic Autoimmune Diseases (2017) (30)
The double reactivity of a human monoclonal rheumatoid factor to IgG and histones is related to distinct binding sites (1988) (30)
Modulation of immune responses with transcutaneously deliverable adjuvants. (2004) (30)
CD4+ T Cells from (New Zealand Black × New Zealand White)F1 Lupus Mice and Normal Mice Immunized Against Apoptotic Nucleosomes Recognize Similar Th Cell Epitopes in the C Terminus of Histone H31 (2003) (30)
Autoimmunity, neuroinflammation, pathogen load: A decisive crosstalk in neuropsychiatric SLE. (2016) (29)
Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus. (1995) (28)
Mapping of linear epitopes of human histone H1 recognized by rabbit anti-H1/H5 antisera and antibodies from autoimmune patients. (1994) (28)
Disease Progression in MRL/lpr Lupus-Prone Mice Is Reduced by NCS 613, a Specific Cyclic Nucleotide Phosphodiesterase Type 4 (PDE4) Inhibitor (2012) (28)
Nuclei of aged myofibres undergo structural and functional changes suggesting impairment in RNA processing. (2009) (28)
The HB-19 pseudopeptide 5[Kpsi(CH2N)PR]-TASP inhibits attachment of T lymophocyte- and macrophage-tropic HIV to permissive cells. (2000) (28)
Diminution of Circulating CD4+CD25high T Cells in Naïve Crohn’s Disease (2009) (27)
Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases. (2019) (27)
Structure of antibody-bound peptides and retro-inverso analogues. A transferred nuclear Overhauser effect spectroscopy and molecular dynamics approach. (2001) (27)
Immunogenicity of free histones and of histones complexed with RNA. (1991) (26)
The N-terminus of HIV-1 Tat protein is essential for Tat-TAR RNA interaction (2005) (26)
Expression of Preproinsulin-2 Gene Shapes the Immune Response to Preproinsulin in Normal Mice1 (2004) (26)
A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91-108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization. (2002) (26)
Isolation of histones and related chromatin structures from spermatozoa nuclei of a dasyurid marsupial, Sminthopsis crassicaudata. (1997) (26)
Successful induction of protective antibody responses against Haemophilus influenzae type b and diphtheria after transcutaneous immunization with the glycoconjugate polyribosyl ribitol phosphate-cross-reacting material 197 vaccine. (2004) (26)
Mimotopes for lupus-derived anti-DNA and nucleosome-specific autoantibodies selected from random peptide phage display libraries: facts and follies. (2005) (26)
Direct Visualization of Peptide/MHC Complexes at the Surface and in the Intracellular Compartments of Cells Infected In Vivo by Leishmania major (2010) (26)
A therapeutic peptide in lupus alters autophagic processes and stability of MHCII molecules in MRL/lpr B cells (2011) (25)
Lupus Regulator Peptide P140 Represses B Cell Differentiation by Reducing HLA Class II Molecule Overexpression (2018) (25)
Localization of two antigenic determinants in histone H4. (1983) (25)
In Vivo Remodeling of Altered Autophagy-Lysosomal Pathway by a Phosphopeptide in Lupus (2020) (25)
Comparison of two different methods using overlapping synthetic peptides for localizing linear B cell epitopes in the U1 snRNP-C autoantigen. (1996) (24)
Rituximab treatment overcomes reduction of regulatory iNKT cells in patients with rheumatoid arthritis. (2010) (24)
The potential of retro-inverso peptides as synthetic vaccines. (1998) (24)
Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif. (1999) (24)
Pre-mRNA Processing Is Partially Impaired in Satellite Cell Nuclei from Aged Muscles (2010) (24)
Protection of swine from foot-and-mouth disease with one dose of an all-D retro peptide. (1999) (24)
Recent advances in solid-phase peptide synthesis and preparation of antibodies to synthetic peptides. (1990) (24)
Peptide-based immunotherapy of systemic lupus erythematosus. (2004) (23)
Modulation of microtubule assembly by the HIV-1 Tat protein is strongly dependent on zinc binding to Tat (2008) (23)
Oxidation and mitochondrial origin of NET DNA in the pathogenesis of lupus (2016) (23)
B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease (2008) (22)
Characterization of a monoclonal antibody reacting with histone H3 (1985) (22)
Progress and Challenges in the Use of MAP1LC3 as a Legitimate Marker for Measuring Dynamic Autophagy In Vivo (2020) (22)
Haemolysin‐derived synthetic peptides with pore‐forming and haemolytic activity (1992) (22)
All-D peptides recognized by an anti-carbohydrate antibody identified from a positional scanning library. (1998) (22)
Blocking nuclear export of HSPA8 after heat shock stress severely alters cell survival (2018) (21)
An autophagy-targeting peptide to treat chronic inflammatory demyelinating polyneuropathies. (2018) (21)
Structural limitations to antigenic mimicry achievable with retroinverso (all-D-retro) peptides. (1996) (21)
Role of peptide backbone in T cell recognition. (1999) (21)
Parkinson's disease is an autoimmune disease: A reappraisal. (2020) (21)
The binding affinity of double‐stranded RNA motifs to HIV‐1 Tat protein affects transactivation and the neutralizing capacity of anti‐Tat antibodies elicited after intranasal immunization (2005) (21)
Histones and DNA ultrastructural distribution in plant cell nucleus: a combination of immunogold and cytochemical methods. (1998) (21)
Heteroclitic properties of mixed α-and aza-β3-peptides mimicking a supradominant CD4 T cell epitope presented by nucleosome (2007) (21)
Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis (2015) (21)
Generation and Characterization of Neutralizing Human Monoclonal Antibodies against Human Immunodeficiency Virus Type 1 Tat Antigen (2004) (20)
A synthetic HIV‐1 Tat protein breaches the skin barrier and elicits Tat‐neutralizing antibodies and cellular immunity (2004) (20)
Important B-cell epitopes for neutralization of human immunodeficiency virus type 1 Tat in serum samples of humans and different animal species immunized with Tat protein or peptides. (2004) (20)
Use of an immobilized enzyme and specific antibodies to analyse the accessibility and role of histone tails in chromatin structure. (1990) (20)
Resetting the autoreactive immune system with a therapeutic peptide in lupus (2015) (20)
The V3 loop-mimicking pseudopeptide 5[Kpsi(CH2N)PR]-TASP inhibits HIV infection in primary macrophage cultures. (1999) (20)
Spliceosomal Peptide P 140 for Immunotherapy of Systemic Lupus Erythematosus Results of an Early Phase II Clinical Trial (2008) (20)
Transcutaneous Immunization with Cross-Reacting Material CRM197 of Diphtheria Toxin Boosts Functional Antibody Levels in Mice Primed Parenterally with Adsorbed Diphtheria Toxoid Vaccine (2008) (19)
Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome. (2020) (18)
Structural and immunological characterisation of heteroclitic peptide analogues corresponding to the 600-612 region of the HIV envelope gp41 glycoprotein. (2002) (18)
Human antinuclear autoantibodies crossreacting with the plasma membrane and the N-terminal region of histone H2B. (1987) (18)
A peptide vaccine administered transcutaneously together with cholera toxin elicits potent neutralising anti-FMDV antibody responses. (2005) (18)
Adamantane-based dendrons for trimerization of the therapeutic P140 peptide. (2014) (18)
Accessibility and structural role of histone domains in chromatin. biophysical and immunochemical studies of progressive digestion with immobilized proteases. (1990) (18)
The importance of implementing proper selection of excipients in lupus clinical trials (2014) (17)
Specificity and effect on apoptosis of Tat antibodies from vaccinated and SHIV-infected rhesus macaques and HIV-infected individuals. (2003) (17)
Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent (2010) (17)
Molecular mimicry between SARS‐CoV‐2 and the female reproductive system (2021) (17)
Applying peptide antigens onto bare skin: induction of humoral and cellular immune responses and potential for vaccination. (2002) (17)
Ikaros Is a Negative Regulator of B1 Cell Development and Function* (2016) (17)
Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus. (2002) (16)
B and T Cell Responses to the Spliceosomal Heterogeneous Nuclear Ribonucleoproteins A2 and B1 in Normal and Lupus Mice (2000) (16)
Nuclei of aged myofibres undergo structural and functional changes suggesting impairment in RNA processing (2009) (16)
Immunomodulation by maternal autoantibodies of the fetal serotoninergic 5-HT4 receptor and its consequences in early BALB/c mouse embryonic development (2007) (16)
IgG autoantibody response in HTLV-I-infected patients. (1995) (16)
TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy (2012) (16)
Emerging peptide therapeutics for inflammatory autoimmune diseases. (2010) (16)
Antitumor vaccination using a major histocompatibility complex (MHC) class I-restricted pseudopeptide with reduced peptide bond. (2000) (15)
Post-translational modifications, subcellular relocation and release in apoptotic microparticles: apoptosis turns nuclear proteins into autoantigens. (2010) (15)
Anti-melanocortin-4 receptor autoantibodies in obesity. (2009) (15)
Influenza Virus-Induced Type I Interferon Leads to Polyclonal B-Cell Activation but Does Not Break Down B-Cell Tolerance (2007) (15)
Multiple autoepitope presentation for specific detection of antibodies in primary biliary cirrhosis (1992) (15)
Immunoprevalence of the CD4+ T‐cell response to HIV Tat and Vpr proteins is provided by clustered and disperse epitopes, respectively (2008) (15)
Tat-neutralizing versus Tat-protecting antibodies in rhesus macaques vaccinated with Tat peptides. (2005) (15)
Histone Autoantibodies Other Than (H2A-H2B)-DNA Autoantibodies (1996) (15)
The Mitochondrion-lysosome Axis in Adaptive and Innate Immunity: Effect of Lupus Regulator Peptide P140 on Mitochondria Autophagy and NETosis (2018) (14)
Lysosomes in acute myeloid leukemia: potential therapeutic targets? (2021) (14)
Receptor–ligand and parasite protein–protein interactions in Plasmodium vivax: Analysing rhoptry neck proteins 2 and 4 (2018) (14)
A flavivirus protein M-derived peptide directly permeabilizes mitochondrial membranes, triggers cell death and reduces human tumor growth in nude mice (2009) (14)
An active mechanism flanks and modulates the export of the small ribosomal subunits (2009) (14)
Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease (2021) (14)
Anti-Ro(SSA) and anti-La(SSB) antibodies in autoimmune rheumatic diseases (1994) (13)
Antibodies to histones in rheumatoid arthritis. (1988) (13)
Highly specific, cross-reactive sequences recognized by an anti-HBsAg antibody identified from a positional scanning synthetic combinatorial library. (1996) (12)
Laboratory protocols for the identification of Th cell epitopes on self-antigens in mice with systemic autoimmune diseases. (2000) (12)
Use of antihistone antibodies with nucleosomes. (1989) (12)
Peptido-targeting of the mitochondrial transition pore complex for therapeutic apoptosis induction. (2006) (12)
MHC class II gene associations with autoantibodies to U1A and SmD1 proteins. (1999) (12)
At least three linear regions but not the zinc-finger domain of U1C protein are exposed at the surface of the protein in solution and on the human spliceosomal U1 snRNP particle. (1998) (11)
Novel trisaccharide based phospholipids as immunomodulators. (2019) (11)
Capability of Neutrophils to Form NETs Is Not Directly Influenced by a CMA-Targeting Peptide (2017) (11)
An Autophagy Modulator Peptide Prevents Lung Function Decrease and Corrects Established Inflammation in Murine Models of Airway Allergy (2021) (11)
Serological abnormalities, including common idiotype PR4, in families with rheumatoid arthritis. (1989) (10)
Mimicry of viral epitopes with retro-inverso peptides of increased stability. (1996) (10)
Epigenetics of Autoantigens: New Opportunities for Therapy of Autoimmune Diseases (2013) (10)
Interaction between certain major histocompatibility complex class II and T-cell receptor V beta alleles promotes the antibody production to extractable nuclear antigen-related peptides. (1997) (9)
Selective Modulation of CD 4 T Cells from Lupus Patients by a Promiscuous , Protective Peptide Analog 1 (2005) (9)
CD4 T Cells from (New Zealand Black New Zealand White)F1 Lupus Mice and Normal Mice Immunized Against Apoptotic Nucleosomes Recognize Similar Th Cell Epitopes in the C Terminus of Histone H3 (2003) (9)
pH-induced conformational changes in chromatin subunits measured by circular dichroism and immunochemical reactivity (1985) (9)
Assessing Autophagy in Sciatic Nerves of a Rat Model that Develops Inflammatory Autoimmune Peripheral Neuropathies (2017) (9)
Regulatory T Cells and Systemic Lupus Erythematosus (2007) (8)
Synthesis and antigenic properties of reduced peptide bond pseudopeptide analogues of a histone H3 hexapeptide. (1994) (8)
HIV‐1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin‐1 binding motif of viral glycoprotein gp41 (2006) (8)
Immunization of rabbits with spermine induces antibodies to self antigens. (1993) (8)
Heteroclitic properties of mixed alpha- and aza-beta3-peptides mimicking a supradominant CD4 T cell epitope presented by nucleosome. (2007) (8)
Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndrome (2012) (8)
Cyclic GMP catabolism up-regulation in MRL/lpr lupus-prone mice is associated with organ remodeling. (2014) (7)
Immunomodulatory consequences of ODN CpG-polycation complexes. (2009) (7)
Anti-“dividing cell antigen” autoantibody: A novel antinuclear antibody pattern related to histones in systemic lupus erythematosus (1993) (7)
Single Insulin-Speci fi c CD 8 + T Cells Show Characteristic Gene Expression Pro fi les in Human Type 1 Diabetes (2011) (7)
Early Apoptotic Reorganization of Spliceosomal Proteins Involves Caspases, CAD and Rearrangement of NuMA (2012) (7)
Nanomaterials, Autophagy, and Lupus Disease (2016) (7)
Immunogenic properties of an anti-DNA antibody-derived peptide, 88H.64-80: location of a dominant idiotope defined by T and B cells. (1998) (6)
Transcriptionally inactive micronuclei, macronuclear anlagen and transcriptionally active macronuclei differ in histone composition in the hypotrichous ciliateStylonychia lemnae (1990) (6)
Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus. (2021) (5)
Characterization of monoclonal antibodies against alpha-hemolysin of Escherichia coli (1991) (5)
[Autophagy in T and B cell homeostasis: recycling for sustainable growth]. (2016) (5)
The pharmacokinetics of 124I-rituximab in patients with rheumatoid arthritis (2011) (5)
Peptide-based therapy in lupus: promising data. (2007) (5)
Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases. (2022) (5)
P140 Peptide Leads to Clearance of Autoreactive Lymphocytes and Normalizes Immune Response in Lupus-Prone Mice (2022) (4)
Peptide Nanostructured Conjugates for Therapeutics (2013) (4)
Interplay of four idiotypes and interaction with autoantibodies in lupus patients, their relatives and their spouses. (1996) (4)
Generation of self-peptides to treat systemic lupus erythematosus. (2014) (4)
Use of synthetic peptides for the analysis of B-cell epitopes in autoantigens (1994) (4)
Excipients: not so inert? When the excipient plays the role of an active substance, as exemplified by systemic lupus. (2018) (3)
Histone deposition and metabolism in embryonic chick lenses during differentiation. (1992) (3)
Specificity of Anti-Histone Autoantibodies in Systemic Rheumatic Disease (1988) (3)
Autoantibodies to hnRNP-A2 in SLE: identification of disease-specific linear epitopes and correlation with disease activity and clinical features (2003) (3)
Dendrimers in immunotherapy and hormone therapy (2020) (3)
The Therapeutic Effect of Phosphopeptide P140 Attenuates Inflammation Induced by Uric Acid Crystals in Gout Arthritis Mouse Model (2022) (3)
Synthetic peptides as tools for diagnosis and therapeutic strategies to treat systemic lupus erythematous. (2012) (3)
Active immunization with anti-DNA autoantibody idiopeptide 88H.64-80 is nephritogenic in (NZB x NZW)F1 and Balb/c mice. (1997) (2)
Immunologically Inert Nanostructures as Selective Therapeutic Tools in Inflammatory Diseases (2021) (2)
Autoantibodies against SUMO1-DHX35 in long-COVID (2022) (2)
LL-37, a Multi-Faceted Amphipathic Peptide Involved in NETosis (2022) (2)
[Autophagy, autoimmunity and autoimmune diseases]. (2017) (2)
The potential of retro-inverso peptides as synthetic vaccines. (1998) (2)
22 – HISTONE AUTOANTIBODIES (2007) (2)
Therapeutic effects of peptide P140 in a mouse periodontitis model (2022) (2)
The Antigenic Structure of Histones (1985) (1)
A Selective Neutraligand for CXCL12/SDF-1α With Beneficial Regulatory Functions in MRL/Lpr Lupus Prone Mice (2021) (1)
Target Autophagy as a Novel Therapeutic Strategy in Autoimmune Diseases (2016) (1)
[Histones and anti-histone antibodies]. (1987) (1)
A1.36 Active immunisation against peptides of vegf improves joint inflammation and destruction in collagen-induced arthritis (2014) (1)
HIV-1 Tat and Apoptotic Death (2005) (1)
CIDP: Current Treatments and Identification of Targets for Future Specific Therapeutic Intervention (2022) (1)
On the potential of retro-inverso peptides in vaccine design (1998) (1)
Multiple Antigen Peptide (MAP) System: Detailed Study of Immunogenic and Antigenic Properties, (1992) (1)
[Soluble tumor necrosis factor receptors in patients with systemic lupus erythematosus]. (1998) (1)
Immunological and translational key challenges in systemic lupus erythematosus: A symposium update. (2023) (1)
Disulphide dimerised peptide creates a crystal contact in an anti-peptide antibody. (2002) (1)
Retropeptides, antibodies directed against the latter, and their use for immunization and the in vitro diagnosis. (1994) (0)
Blocking nuclear export of HSPA8 after heat shock stress severely alters cell survival (2018) (0)
The therapeutic P140 peptide, a new immunomodulating tool for lupus may have applications in other chronic inflammatory conditions (2016) (0)
SYNTHETIC PEPTIDE CORRESPONDING TO THE MAJOR IMMUNOGEN SITE OF FMD VIRUS, NMR, 10 STRUCTURES (1998) (0)
peptide analogues, and their uses in particular in pharmaceutical compositions for the diagnosis and (1997) (0)
De l'Aza-β3Amino Acide aux Peptides Hybrides Immunomodulateurs : Etude Structurale et Evaluation Biologique. (2007) (0)
Immunogenicity of a liposome-associated synthetic hexapeptide antigen (1991) (0)
P.298 Diminution des lymphocytes CD4+CD25high (Tregs) circulants au cours de la rectocolite hémorragique (RCH) : comparaison avec la maladie de Crohn colique (MC) (2009) (0)
Protein microarray characterization of the autoantibody response in systemic lupus erythematosus and related diseases (2001) (0)
Solution structure of lactam analogue DapD of HIV gp41 600-612 loop (2003) (0)
LigandContributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response Graphical (0)
Comparative analysis of anti-histone and anti-chromatin antibody specificity in lupus erythematosus cell-positive and -negative sera and their relation to disease activity (2001) (0)
Clinical Significance of Anti-Ubiquitin Antibodies in Systemic Lupus Erythematosus (1989) (0)
Solution structure of beta3 analogue peptide (HCYS) of HIV gp41 600-612 loop. (2003) (0)
Active immunization (vaccination) against peptides of IL-1β induces self anti-IL-1β antibodies and protects against collagen-induced arthritis (2005) (0)
Synthetic peptides vaccines for hiv: the epdope of cbd as an effective immunogen to provide wide neutralizing antibodies against hiv. (2003) (0)
Solid phase synthesis and immunological properties of cyclic peptides of the hemagglutinin of influenza virus (1990) (0)
Autophagy pathway as a target of therapeutic P140 peptide used in lupus (2017) (0)
SOLUTION STRUCTURE OF CGGIRGERG IN CONTACT WITH THE MONOCLONAL ANTIBODY MAB 4X11, NMR, 11 STRUCTURES (1999) (0)
Autophagy in neuroin fl ammatory diseases (0)
Early differentiated plasma cells expressing CXCR3 are attracted to inflamed kidneys in lupus (2011) (0)
[The spliceosome and its interest for lupus therapy]. (2007) (0)
Retro peptides, antibodies against it, and their uses in diagnosis and vaccination in vitro (1995) (0)
Peptide analogues as vaccines and immunomodulators (1999) (0)
Chapter 23 – Histone Autoantibodies (2014) (0)
Synthetic peptide HIV vaccine: the CBD epitope as an efficient immunogen for the induction of HIV-neutralizing antibodies (2003) (0)
[Immunogenetics of systemic lupus: adequacy between HLA molecules class II and the germinal genes of antigen receptor of T-lymphocytes favours the production of various antibodies]. (1993) (0)
[Among the antinuclear antibodies in rheumatoid polyarthritis: antihistone antibodies detected by an immunoenzymatic technic]. (1988) (0)
The role of lysosomes in metabolic and autoimmune diseases (2023) (0)
Utilisation de composés dérivés de l'adénine pour le traitement du lupus use of adenine-derived compounds for the treament of lupus (2014) (0)
Lysosomes as a therapeutic target (2019) (0)
Presence ofantibodies toubiquitin during theautoimmune response associated withsystemic lupuserythematosus (1988) (0)
synthetic peptides conjugated ubiquitin and histone H2A (1989) (0)
[Ubiquitin and degenerative diseases of the central nervous system]. (1992) (0)
Aberrant macroautophagy and cleaved C3 production in MRL/lpr hippocampus (2019) (0)
Immunochemical localization oftheC-terminal hexapeptide of histone H3atthesurface ofchromatin subunits (1982) (0)
Altered expression of glomerular ectonucleotidase in kidney grafts with delayed function. (1996) (0)
The abscopal effect: Implications for drug discovery in autoimmunity. (2023) (0)
Chapter 29 SARS-CoV-2, fertility-related autoantibodies and reproductive injury (2023) (0)
Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis (2015) (0)
Chapter 3 Innate immune responses in COVID-19 (2023) (0)
A2 and B1 in Normal and Lupus Mice Heterogeneous Nuclear Ribonucleoproteins B and T Cell Responses to the Spliceosomal (2000) (0)
modified peptides and their use to treat autoimmune diseases (2011) (0)
Solution structure of lactam analogue (DDap) of gp41 600-612 loop of HIV (2003) (0)
Genetic and environmental factors in Systemic lupus erythematosus (1994) (0)
Immunogénétique du lupus systémique: l'adéquation entre molécules HLA de classe II et gènes germinaux du récepteur d'antigènes des lymphocytes T favorise la production de certains anticorps. (1993) (0)
CTL Specific for an Influenza Virus Epitope Pseudopeptide Modulates the Cytokine Profile of A Partially Modified Retro-Inverso (1998) (0)
Interaction between TCR beta genes and HLA DR-DQ genes determines the response to autoantigen peptides in SLE patients and family members (1993) (0)
Solution structure of the lactam analogue EDap of HIV gp41 600-612 loop. (2003) (0)
An Efficient Test Battery for Rapid Screening of Extrapyramidal Side-Effects of Phenothiazine Analogues (2017) (0)
Aza-peptides and methods of use for the treatment and prevention of immunological disorders. (2006) (0)
Dendrimers in immunotherapy and hormone therapy in Pharmaceutical applications of dendrimers (2020) (0)
Multireprésentation of a peptide substrate analogue of DPPIV, including KPR type, in order to inhibit the entry of HIV into cells. (1994) (0)
New molecules MULTIMERIC, their process for the preparation, and their use for the preparation of drugs (2002) (0)
the Nonobese Diabetic Mouse T Cell Response to Preproinsulin I and II in (2002) (0)
Synthetic Peptides an Probes for Autoantibodies (1989) (0)
Solution structure of synthetic cyclic peptide mimicking the loop of HIV-1 gp41 glycoprotein envelope (2002) (0)
[Novel strategy in lupus therapy: from the peptide P140 to Lupuzor™]. (2011) (0)
RETRO-INVERSO ANALOGUE OF THE G-H LOOP OF VP1 IN FOOT-AND-MOUTH-DISEASE (FMD) VIRUS, NMR, 10 STRUCTURES (1999) (0)
New multimeric molecules, processes for their preparation, and their use for the production of medicines (2003) (0)
structure of the spliceosomal phosphopeptide P140 (non-phosphorylated form) (2010) (0)
Design, synthesis and immunogenic properties of a novel class of peptidomimetics (2005) (0)
Immune response to hn and snRNP in autoimmune mice. A model for the development of lupus autoimmunity by a single initiator T helper epitope? (2001) (0)
Solution structure of beta3-analogue peptide corresponding to the gp41 600-612 loop of HIV. (2003) (0)
Anti-dividing cell antigen a novel antinuclear antibody in systemic lupus erythematosus (1989) (0)
The Role of Post Synthetic Histone Modifications on Chromatin Conformation: an Immunochemical Study (1985) (0)
Use of compounds derived from adenine to treat lupus (2006) (0)
Protein microarray characterization of autoantibody responses in rheumatoid arthritis and systemic lupus erythematosus (2002) (0)
Normal Mice the Immune Response to Preproinsulin in Expression of Preproinsulin-2 Gene Shapes (2003) (0)
SOLUTION STRUCTURE OF THE ANALOGUE RETRO-INVERSO (mA-R)REGRIGGC IN CONTACT WITH THE MONOCLONAL ANTIBODY MAB 4X11, NMR, 6 STRUCTURES (1999) (0)
P.300 Expression de l’intégrine β7 par les lymphocytes circulants CD4+, les lymphocytes Tregs (CD4+CD25high) et les lymphocytes CD4+CD25low au cours de la maladie de Crohn (MC) (2009) (0)
Clinical Connections (2018) (0)
[Ubiquitinated nuclear proteins and systemic lupus erythematosus]. (1991) (0)
The pharmacokinetics of ¹²⁴I-rituximab in patients with rheumatoid arthritis. (2011) (0)
Neuropsychiatric lupus: autophagy and inflammation (2018) (0)
Mappingofepitopes on U1 snRNPpolypeptide A with synthetic peptides andautoimmune sera (1991) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Sylviane Muller?

Sylviane Muller is affiliated with the following schools:

Sylviane Muller's Academic­Influence.com Rankings

Sylviane Muller's Degrees

Why Is Sylviane Muller Influential?

Sylviane Muller's Published Works

Published Works

What Schools Are Affiliated With Sylviane Muller?

Sylviane Muller's AcademicInfluence.com Rankings